Mostrar el registro sencillo del ítem
A phase 3, active (warfarin) controlled, double-blind, double-dummy, randomized study for assessing the efficacy and safety of rivaroxaban in patients with non-valvular atrial fibrilation
dc.contributor.advisor | Στεφανίδης, Ιωάννης Λ. | el |
dc.creator | Καραγιαννίδης, Ευστράτιος | el |
dc.date.accessioned | 2017-04-26T09:09:49Z | |
dc.date.available | 2017-04-26T09:09:49Z | |
dc.date.issued | 2015 | |
dc.identifier.other | 14320 | |
dc.identifier.uri | http://hdl.handle.net/11615/46172 | |
dc.identifier.uri | http://dx.doi.org/10.26253/heal.uth.4432 | |
dc.language.iso | en | en |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en |
dc.subject.other | Καρδιαγγειακό σύστημα -- Φάρμακα | el |
dc.subject.other | Βιοστατιστική | el |
dc.title | A phase 3, active (warfarin) controlled, double-blind, double-dummy, randomized study for assessing the efficacy and safety of rivaroxaban in patients with non-valvular atrial fibrilation | en |
dc.type | masterThesis | en |
heal.recordProvider | Πανεπιστήμιο Θεσσαλίας - Βιβλιοθήκη και Κέντρο Πληροφόρησης | el |
heal.academicPublisher | Πανεπιστήμιο Θεσσαλίας. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής. | el |
heal.academicPublisherID | uth | en |
heal.fullTextAvailability | true | en |
dc.rights.accessRights | free | en |